High-Energy Protons Fight Cancer on Earth and in Space
Just as scientists use high-energy protons to create isotopes used to detect and treat cancer, these same high-energy protons can pose a risk to spacecraft and the health of the astronauts traveling in them. These risks mean spacecraft must have protective shielding. Unfortunately, scientists have a great deal of uncertainty concerning the risks posed by these high-energy protons. To learn more about the risks and about using these protons to produce isotopes, scientists measured the cross sections (probabilities) for high-energy proton reactions used to produce important new radiopharmaceuticals.
Measuring these cross sections allows scientists to optimize the quantity and purity of medical isotopes needed in the ﬁght against cancer. These include producing the pharmaceuticals arsenic-72-HBED and gallium-68-DOTATOC using high-energy protons from particle accelerators. Doctors use these pharmaceuticals to show where tumors have spread in the body. However, high-energy protons are also a dangerous type of space radiation. Better understanding their behavior and reactions allows scientists to improve the design of shielding that protects astronauts and electronics in spacecraft. This will allow us to explore other planets in our solar system, while also helping understand how nuclei absorb and release energy.
Researchers from Brookhaven National Laboratory, Los Alamos National Laboratory, and Lawrence Berkeley National Laboratory performed a series of experiments using proton beams from the Brookhaven Linac Isotope Producer, the Los Alamos Isotope Production Facility, and the Berkeley Laboratory 88-Inch Cyclotron. These experiments measured production rates for 78 isotopes from the proton bombardment of niobium and arsenic targets with energies up to 200 MeV, including two radionuclides used for PET and one used to monitor the dose from proton beams in accelerators.
The team compared this large body of production data to predictions made using state-of-the-art nuclear reaction modeling codes to explore how quickly the energy from an incoming proton spreads throughout the entire nucleus when the two collide. The results showed a signiﬁcantly slower rate of energy dissipation in the nucleus compared to what scientists previously believed. This decrease, in turn, leads to an increase in the emission of additional “secondary” high-energy protons and neutrons, and also shows strikingly different rates when producing isotopes with different proton-to-neutron ratios. Taken together, these results provide guidance for the optimized production of the two PET radionuclides and will help in the design of shielding for spacecraft and their occupants from “secondary” particles caused by protons in cosmic radiation.
Call for Papers
ARO is seeking original case reports, research articles, and review articles on innovative topics offering practical applications in radiation oncology. Manuscripts undergo a double-blinded external peer review process, and there is no submission fee.
- First Clinical Results Published for 177Lu-rhPSMA-10.1 in mCRPC Trial
- Opaganib Shown to Protect Against Radiation-Induced Lung Inflammation
- Fusion Licenses Actinium-Based PSMA Targeted Radiotherapy From Heidelberg University and Euratom
- Future of Theranostics in Neurooncology Looks Promising With Recent Advancements
- First Cellular Therapy for Unresectable or Metastatic Melanoma Receives FDA Approval